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Abstract: Walking tests, such as the 6-min walk test (6MWT), are popular methods of estimating
peak oxygen uptake (VO2peak) in clinical populations. However, the strength of the distance vs.
VO2peak relationship is not strong, and there are no equations for estimating ventilatory threshold
(VT), which is important for training prescription and prognosis. Since the 6MWT is often limited
by walking mechanics, prediction equations that include simple additional predictors, such as the
terminal rating of perceived exertion (RPE), hold the potential for improving the prediction of
VO2max and VT. Therefore, this study was designed to develop equations for predicting VO2peak
and VT from performance during the 6MWT, on the basis of walking performance and terminal RPE.
Clinically stable patients in a cardiac rehabilitation program (N = 63) performed the 6MWT according
to the American Thoracic Society guidelines. At the end of each walk, the subject provided their
terminal RPE on a 6–20 Borg scale. Each patient also performed a maximal incremental treadmill
test with respiratory gas exchange to measure VO2peak and VT. There was a good correlation
between VO2peak and 6MWT distance (r = 0.80) which was improved by adding the terminal RPE
in a multiple regression formula (6MWT + RPE, R2 = 0.71, standard error of estimate, SEE = 1.3
Metabolic Equivalents (METs). The VT was also well correlated with walking performance, 6MWT
distance (r = 0.80), and was improved by the addition of terminal RPE (6MWT + RPE, R2 = 0.69,
SEE = 0.95 METs). The addition of terminal RPE to 6MWT distance improved the prediction of
maximal METs and METs at VT, which may have practical applications for exercise prescription.
Keywords: physical fitness; internal load; RPE; performance
1. Introduction
Exercise capacity is an important quantitative expression of the ability to perform
muscular activity. Specifically, the peak oxygen uptake (VO2peak), used when there is no
confirmatory test to prove that a single-measured VO2peak is equivalent to the classical def-
inition of VO2max, and the ventilatory threshold (VT) are well correlated with performance
in individuals capable of performing prolonged heavy exercise [1–3]. As an integrator of
the elements of the Fick equation, VO2peak is a strong index of overall cardio-pulmonary
function [4], and a very strong predictor of survival in clinical populations [5–8]. Similarly,
VT, although a physiologically complex concept [9], has come to be recognized as a better
measure of exercise capacity than VO2peak relative to the ability to carry out daily activi-
ties [2,3]. It has also been shown to be an important prognostic marker [10,11]. Normally,
cardiopulmonary exercise testing (which is technically demanding) [12] is required to
measure VO2peak and VT. directly However, cardiopulmonary exercise testing is normally
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only conducted for the purpose of exploring the differential diagnosis of dyspnea or to
determine if there is a multi-organ system explanation of exercise intolerance.
Traditionally VO2peak and VT are measured in the laboratory, during incremental
exercise, on either a treadmill or cycle ergometer, with direct measurement of respiratory
gas exchange and/or lactate accumulation [12,13]. However, the technical requirements
for performing such evaluations are considerable. A variety of predictive equations for
VO2peak have been developed [14–16]. Although providing reasonable accuracy, they
typically require maximal effort exercise testing, which can be challenging and unpleas-
ant for patients and present at least some safety concerns [17]. Accordingly, a number
of less technically demanding methods based on real-world ambulatory patterns have
arisen [6,7,18–22] which are widely deployed in the fitness and clinical exercise physiology
communities. In particular, the 6-min walk test (6MWT) in clinical populations [6,7] and
the Rockport 1-mile walking test [21] and the 2-km walking test [22] in fitness populations
have shown utility in terms of predicting VO2peak. Recent data have also suggested that
the VT may be predicted from incremental exercise tests based on simple performance
measures [23–26].
In some of the waking tests used to predict functional capacity, the analytic strategy
is based on starting with a population estimate, with that estimate adjusted for walking
performance and with further adjustments made on the basis of terminal heart rate (HR)
(e.g., smaller reductions in points on the basis of shorter walking times or lower terminal
HR). Some equations [21,22] also adjust on the basis of other variables such as age, sex,
height, weight, or body mass index (BMI). This solution is attractive and relatively simple,
with independent studies demonstrating good estimates of VO2peak compared to walking
performance alone [23].
However, because of the wide interindividual variability in the HR response and
maximal HR, and of the profound effect of many medications on the HR response, it would
be desirable to find a method of replacing the HR measure in these prediction equations.
Eston et al. [20] have suggested that the progression of the rating of perceived exertion
(RPE) during incremental exercise can be used as a tool for predicting VO2peak. Following
this line of thinking, Alamji et al. [23] have suggested that the RPE could also be used to
predict VT.
Given that simple walking tests such as the 6MWT are much more assessable to the
exercising community than laboratory-based tests, and that most training takes place at
intensities just below the VT [3], this study was designed to determine whether data from
the 6MWT, with walking performance and terminal RPE as predictor variables, could be
used to develop adequate prediction equations for VO2peak and VT.
2. Materials and Methods
The subjects for the study were 63 adult volunteers. All were participants in either a
Phase II cardiac rehabilitation program or a community-based exercise program, designed
for the primary and secondary prevention of cardiovascular disease. Diagnoses for patients
were conventional: stable angina pectoris (n = 2), post myocardial infarction (n = 22), post
revascularization surgery (n = 18), post percutaneous intervention (n = 14), stable heart
failure (n = 7), and risk factors for cardiovascular disease (n = 25). The research protocol
was approved by the University of Wisconsin-La Crosse Institutional Review Board for
the Protection of Human Subjects (Protocol 13-HB-001, approved 13 December 2013). All
subjects provided written informed consent before participation.
Each subject performed an incremental treadmill exercise test to fatigue or to clinical
signs and symptoms [13] with continuous electrocardiographic (ECG) and hemodynamic
monitoring. A modified Balke type protocol was used, with the treadmill speed individ-
ually selected to represent comfortable walking during the first 2-min stage, and with
subsequent increments in workload provided by 2% increments in treadmill grade every
stage. Respiratory metabolism was measured with open-circuit spirometry using a mixing
chamber based metabolic system (AEI Industries, Pittsburgh, PA, USA). The pneumotach
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was calibrated with a 3-L syringe, and the gas analyzers were calibrated using a reference
gas (4% CO2, 16% O2) and room air. Gas exchange was integrated every 30 s, and the
highest 30 s VO2 was accepted as VO2peak. The VT was identified using both the v-slope
and ventilatory equivalent methods [2]. Because the intent of the study was to predict
exercise capacity from 6MWT performance, the VO2prak and the VO2 at the VT (VO2@VT)
was expressed as maximal Metabolic Equivalents (METs) (Max METs), and METs at the VT
(METs@VT), as we felt that this was more clinically relevant and comparable to estimates
of exercise capacity based on performance in standard exercise protocols [13–16]. On
a separate day, always within 72 h, each subject performed a 6MWT on a 30-m course
with standard conditions and prompting, according to the American Thoracic Society [27].
The distance completed was measured to the nearest meter using laps completed and
interpolation between cones placed at 5-m intervals on the walking course. Within 30 s
of concluding the 6MWT, the terminal RPE was measured using the classical (6–20) Borg
scale [28]. Instructions for using the RPE scale had been discussed with the subject before
the start of the 6MWT.
The relationships of 6MWT with Max METs and METs@VT were made using linear
regression. Similarly, the relationships of the terminal RPE with Max METs and METs@VT
were made using linear regression. Regression equations for predicting Max METs and
METs@VT were constructed using multiple linear regression with a stepwise approach,
with 6MWT distance entered first and terminal RPE entered second.
3. Results
The characteristics of the subjects are presented in Table 1, with the subjects presented
both by sex and as a total group. They were broadly representative of patients in contem-
porary preventive/rehabilitation programs in terms of age, diagnoses, and medications.
Table 1. Mean and standard deviation of the characteristics of the subjects.





Age (years) 60.2 ± 9.7 55.4 ± 10.1 59.6 ± 10.0
Height (m) 1.78 ± 0.06 1.62 ± 0.06 1.74 ± 0.09
Weight (kg) 94.4 ± 19.1 65.4 ± 12.7 86.8 ± 21.8
6MWT Distance (m) 583 ± 106 600 ± 87 587 ± 101
6MWT RPE 12.1 ± 2.0 12..3 ± 2.3 12.1 ± 2.1
Max METS 7.8 ± 2.3 8.4 ± 2.4 8.1 ± 2.4
METs@VT 5.8 ± 1.4 6.8 ± 2.0 5.9 ± 1.7
Maximal HR 144 ± 24 161 ± 21 149 ± 24
6MWT: 6-min walk test; RPE: rating of perceived exertion; Max METS: maximal Metabolic Equivalents; METs@VT:
Metabolic Equivalents at ventilatory threshold; HR: heart rate.
The bivariate relationships between 6MWT distance versus Max METs and METs@VT,
and between terminal RPE vs. Max METs and METs@VT, are presented in Figure 1. There
was a strong and significant simple correlation between 6MWT distance versus Max METs
(r = 0.80) and METs@VT (r = 0.80), and a weak but statistically significant correlation
between terminal RPE versus Max METs (r = 0.30) and METs@VT (r = 0.23).
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Figure 1. Bivariate relationship between the 6-min walk test (6MWT) distance and the maximal
Metabolic Equivalents (Max METs, (a)), the terminal rating of perceived exertion (RPE) and Max
METs (b), the 6MWT distance and Metabolic Equivalents at the ventilatory threshold (METs@VT, (c))
and the terminal RPE and METs@VT (d).
When the 6MWT distance and terminal RPE were combined in a multiple regression
equation to predict Max METs, the R2 increased from 0.63 to 0.71, with a SEE of 1.3 METs
and a standardized residual of 1.0 METs. The prediction equation was:
Max METs = 0.882 + (0.018 * 6MWT m) − (0.308 * RPE) (1)
When the 6MWT distance and terminal RPE were combined in a multiple regression
equation to predict METs@VT, the R2 increased from 0.64 to 0.69, with a SEE of 0.95 METs
and a standardized residual of 0.7 METs. The prediction equation was:
METs@VT = 0.140 + (0.013 * 6MWT m) − (0.161 * RPE) (2)
When the derived prediction formulas for Max METs and METs@VT were plotted
against the measured Max METs (r = 0.87) and METs@VT (r = 0.85), there was a strong
bivariate relationship for both. The residual scores (predicted-observed) revealed a small
value for both Max METS (−0.27 ± 1.24 METs) and METs@VT (−0.14 ± 0.92 METs), with
most of the outliers at a relatively higher exercise capacity (Figure 2).
Figure 2. Cont.
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Figure 2. Bivariate relationship between the 6-min walk test (6MWT) + terminal rating of perceived
exertion (RPE) prediction equations and observed values for maximal Metabolic Equivalents (Max
METs, a), Metabolic Equivalents at the ventilatory threshold (METs@VT, b) and the standardized
residuals for Max METs (c) and METs@VT (d).
Tabular presentations of Max METs and METs@VT in relation to 6MWT distance and
terminal RPE are presented in Tables 2 and 3. In terms of convenience of use, it is simple to
compare 6MWT distance and terminal RPE to derive Max METs and METs@VT.
Table 2. Estimate of maximal Metabolic Equivalents in relation to 6-min walk test (6MWT) distance (m) and terminal rating
of perceived exertion (RPE). For convenience of presentation, 6MWT distance is incremented by 50 m. However, as the
equation is linear, interpolation of intermediate values is appropriate.
RPE
Distance
(m) 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
200 2.63 2.33 2.02 1.71 1.40
225 3.08 2.78 2.47 2.16 1.85 1.54
250 3.53 3.23 2.92 2.61 2.30 1.99 1.69
275 3.98 3.68 3.37 3.06 2.75 2.44 2.14 1.83 1.52
300 4.43 4.13 3.82 3.51 3.20 2.89 2.59 2.28 1.97 1.66
325 4.88 4.58 4.27 3.96 3.65 3.34 3.04 2.73 2.42 2.11 1.80
350 5.33 5.03 4.72 4.41 4.10 3.79 3.49 3.18 2.87 2.56 2.25 1.95 1.64
375 5.78 5.48 5.17 4.86 4.55 4.24 3.94 3.63 3.32 3.01 2.70 2.40 2.09 1.78
400 6.23 5.93 5.62 5.31 5.00 4.69 4.39 4.08 3.77 3.46 3.15 2.85 2.54 2.23 1.92
425 6.68 6.38 6.07 5.76 5.45 5.14 4.84 4.53 4.22 3.91 3.60 3.30 2.99 2.68 2.37
450 7.13 6.83 6.52 6.21 5.90 5.59 5.29 4.98 4.67 4.36 4.05 3.75 3.44 3.13 2.82
475 7.58 7.28 6.97 6.66 6.35 6.04 5.74 5.43 5.12 4.81 4.50 4.20 3.89 3.58 3.27
500 8.03 7.73 7.42 7.11 6.80 6.49 6.19 5.88 5.57 5.26 4.95 4.65 4.34 4.03 3.72
525 8.48 8.18 7.87 7.56 7.25 6.94 6.64 6.33 6.02 5.71 5.40 5.10 4.79 4.48 4.17
550 8.93 8.63 8.32 8.01 7.70 7.39 7.09 6.78 6.47 6.16 5.85 5.55 5.24 4.93 4.62
575 9.38 9.08 8.77 8.46 8.15 7.84 7.54 7.23 6.92 6.61 6.30 6.00 5.69 5.38 5.07
600 9.83 9.53 9.22 8.91 8.60 8.29 7.99 7.68 7.37 7.06 6.75 6.45 6.14 5.83 5.52
625 10.28 9.98 9.67 9.36 9.05 8.74 8.44 8.13 7.82 7.51 7.20 6.90 6.59 6.28 5.97
650 10.73 10.43 10.12 9.81 9.50 9.19 8.89 8.58 8.27 7.96 7.65 7.35 7.04 6.73 6.42
675 11.18 10.88 10.57 10.26 9.95 9.64 9.34 9.03 8.72 8.41 8.10 7.80 7.49 7.18 6.87
700 11.63 11.33 11.02 10.71 10.40 10.09 9.79 9.48 9.17 8.86 8.55 8.25 7.94 7.63 7.32
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Table 3. Estimate of Metabolic Equivalents at the ventilatory threshold in relation to 6-min walk test (6MWT) distance (m)
and terminal rating of perceived exertion (RPE). For convenience of presentation, 6MWT distance is incremented by 50 m.
However, as the equation is linear, interpolation of intermediate values is appropriate.
RPE
Distance
(m) 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
200 1.83 1.68 1.53 1.38 1.23
225 2.10 1.94 1.78 1.62 1.46
250 2.42 2.26 2.10 1.94 1.78 1.62 1.46
275 2.75 2.59 2.43 2.27 2.11 1.94 1.78 1.62 1.46
300 3.07 2.91 2.75 2.59 2.43 2.27 2.11 1.95 1.79 1.63 1.46
325 3.40 3.24 3.08 2.92 2.76 2.59 2.43 2.27 2.11 1.95 1.79 1.63 1.47
350 3.72 3.56 3.40 3.24 3.08 2.92 2.76 2.60 2.44 2.28 2.11 1.95 1.79 1.63
375 4.05 3.89 3.73 3.57 3.41 3.24 3.08 2.92 2.76 2.60 2.44 2.28 2.12 1.96 1.80
400 4.37 4.21 4.05 3.89 3.73 3.57 3.41 3.25 3.09 2.93 2.76 2.60 2.44 2.28 2.12
425 4.70 4.54 4.38 4.22 4.06 3.89 3.73 3.57 3.41 3.25 3.09 2.93 2.77 2.61 2.45
450 5.02 4.86 4.70 4.54 4.38 4.22 4.06 3.90 3.74 3.58 3.41 3.25 3.09 2.93 2.77
475 5.35 5.19 5.03 4.87 4.71 4.54 4.38 4.22 4.06 3.90 3.74 3.58 3.42 3.26 3.10
500 5.67 5.51 5.35 5.19 5.03 4.87 4.71 4.55 4.39 4.23 4.06 3.90 3.74 3.58 3.42
525 6.00 5.84 5.68 5.52 5.36 5.19 5.03 4.87 4.71 4.55 4.39 4.23 4.07 3.91 3.75
550 6.32 6.16 6.00 5.84 5.68 5.52 5.36 5.20 5.04 4.88 4.71 4.55 4.39 4.23 4.07
575 6.65 6.49 6.33 6.17 6.01 5.84 5.68 5.52 5.36 5.20 5.04 4.88 4.72 4.56 4.40
600 6.97 6.81 6.65 6.49 6.33 6.17 6.01 5.85 5.69 5.53 5.36 5.20 5.04 4.88 4.72
625 7.30 7.14 6.98 6.82 6.66 6.49 6.33 6.17 6.01 5.85 5.69 5.53 5.37 5.21 5.05
650 7.62 7.46 7.30 7.14 6.98 6.82 6.66 6.50 6.34 6.18 6.01 5.85 5.69 5.53 5.37
675 7.95 7.79 7.63 7.47 7.31 7.14 6.98 6.82 6.66 6.50 6.34 6.18 6.02 5.86 5.70
700 8.27 8.11 7.95 7.79 7.63 7.47 7.31 7.15 6.99 6.83 6.66 6.50 6.34 6.18 6.02
4. Discussion
The main finding of this study was that adding the terminal RPE to 6MWT distance
significantly improved the predictability of Max METs. Unique to this study was the ability
of 6MWT distance + terminal RPE also to predict the METs@VT, which is a better measure
of sustainable exercise capacity [2,9], a powerful emerging measure of prognosis [10,11]
and a very useful measure for prescribing exercise [3]. It may also be of particular value
in patients with cardiovascular disease who are often on medications that alter the HR
response during both exercise testing and training.
The goodness of fit of the equations for predicting Max METs from the 6MWT distance
+ terminal RPE (R2 = 0.71) compares favorably with field tests using the 6MWT distance
(R2 = 0.42) [6], the Rockport 1-mile Walking Test (R2 = 0.78) [21] or R2 = 0.71) [23], the
Cooper 12-min run-walk Test (R2 = 0.80) [19], or with extrapolation of submaximal RPE
(R2 = 0.85) [20] or (R2 = 0.71) [23]. The SEE for all of these predictions equations is on the
order of 1.0–1.5 METs. Although the correlation of treadmill protocol time vs. Max METs
(e.g., VO2max) is typically higher (R2 = 0.83–0.94), the SEE is also typically in the range of
1 MET [15,16,29,30]; thus, the simplicity of the 6MWT + terminal RPE is very attractive.
The prediction of METs@VT has more typically been performed using percentages of
the maximal power output [25], running speed [23], RPE [23], or as the equivocal stage of
the Talk Test [26]. To our knowledge, an approach to estimating the METs@VT in a clinical
population with an approach as simple as that used in this study has not previously been
reported. Given the importance of the VT in terms of the evaluation of prognosis [10,11]
and exercise prescription [3], and the ability of equation-based methods to account for
speed and grade equivalents of the METs@VT [31], the ability to predict METs@VT from
6MWT distance + terminal RPE may be of considerable utility.
The workload required to achieve a particular value for the percentage of Max METS
(%Max METS), percentage of HR (%HR) reserve, or METs@VT is probably lower than the
workload eliciting these markers during exercise testing. Recent research from our labora-
tory [30] has suggested that “translating” exercise test results to exercise training requires a
downregulation of the MET requirement of the workload to ~70–75% of that where a given
physiologic response is observed during exercise testing. From that perspective, consider a
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patient who completes 475 m during the 6MWT, with a terminal RPE of 14. The predicted
Max METs would be 5.12 (Table 2), and the METs@VT would be 4.07 (Table 3). Translating
to 72% of METs@VT would yield a training intensity of 2.93 METs. Based on the American
College of Sports Medicine (ACSM) ambulation equations [31], this workload should be
achieved during level-ground ambulation at ~1.13 m*s−1 (2.5 mph or 4.1 kph). One would
anticipate a RPE during training of ~13 (which has been proposed as the “ideal” intensity
for many people) [32] and with comfortable speech still possible [26]. The training load
can, of course, be adjusted after the first training bout, but this simple modification of the
6MWT and the simple approach to translating from testing to training [30] suggests a way
to define easily the exercise component of the individualized treatment plan for patients in
rehabilitation programs.
Another advantage of the 6MWT distance + terminal RPE approach is the ability to
make outcome assessments in patients who are mechanically limited to a top walking
speed. The 6MWT was originally created for patients with pulmonary disease or heart
failure [6,7,26], who often have very limited exercise capacity. In the absence of routine
graded exercise testing, and in need of methods for outcome assessment, the 6MWT has
more recently been widely used with relatively healthier patients in cardiac rehabilitation
programs. These patients often have better exercise capacity and are often constrained
by the requirement to only walk during the 6MWT, with a top walking speed unlikely
to exceed 2.0 m·s−1 (4.5 mph or 7.2 kmh) which requires a VO2 of ~16 mL·kg−1·min−1
(~4.4 METs) [31]. Since common clinical experience shows that many patients can achieve
this walking speed more or less comfortably, outcome assessment in rehabilitation pro-
grams has been constrained by the use of the 6MWT distance alone. However, in a patient
who originally walks 450 m with a RPE of 15, who later walks the same 450 m, but with a
RPE of 13, the calculated MaxMETs (4.36 to 4.98 METs) and METs@VT (3.58 to 3.90 METs)
improve by 14% and 9%, respectively. Additionally, this follow-up testing can be used to
update the exercise proscription.
Although the present study provides meaningful information, some limitations should
be acknowledged. First, this study is a small cohort study. Therefore, future researched
should consider a larger sample. Second, the present study did not include a large rep-
resentation of the heart failure population (i.e., potential heart transplant candidates and
those with pulmonary hypertension) in which VO2max might have huge significance, in
particular, as most of the times it is hard to obtain cardiopulmonary exercise testing in a
heart-failure population, and rough estimates based on 6MWT will be of paramount im-
portance.
5. Conclusions
The results of this study demonstrate that the simple approach of adding the terminal
RPE to the 6MWT distance can improve the estimate of Max METs in patients in rehabilita-
tion programs. Additionally, it can be used to make an estimate of the METs@VT, which is
important prognostically [10,11] as a better estimate of sustainable exercise capacity [2] and
is highly important prescriptively [3]. Lastly, this approach to estimating Max METs and
METs@VT may provide a solution to estimating changes in exercise capacity in patients
who are mechanically at the limit of their walking speed capacity.
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